Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO > SMART QUOTES

Smart Quotes

Divi's Laboratories Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	532488
ISIN Demat	INE361B01024
Book Value	561.09

NSE Code	DIVISLAB
Dividend Yield %	0.46
Market Cap	1739243.95

P/E	78.73
EPS	83.21
Face Value	2


	BSE		NSE

06-Jun-2025

Last Price	6551.60
Net Change	-78.55
% Change	-1.18%
Prev.Close	6630.15
Open	6648.35
High	6648.35
Low	6502.55
Volume	19749

Last Price	6544.50
Net Change	-84
% Change	-1.27%
Prev.Close	6628.50
Open	6630.00
High	6630.00
Low	6505.00
Volume	361092

Value	128825987
Best Buy	0.00
Best Sell	0.00
Best Quantity	0
Sell Quantity	0
Today's Range	6648.35
52-Week High	6764.00
52-Week Low	4396.60

Value	2358222820.5
Best Buy	6544.50
Best Sell	0.00
Best Quantity	89
Sell Quantity	0
Today's Range	6630.00
52-Week High	6764.00
52-Week Low	4395.30

Open Price	6640.00
High Price	6640.00
Low Price	6531.50
Last Price	6582.00
Prev Close	6657.50
Change	-75.50
% Change	-1.13 %

Average Price	6563.78
Underlying Value	6544.50
Number of contracts traded	4546
Turnover in Rs. Lakhs	29839
Open Interest	2975700.00
Change in O I	36300.00
% Change in O I	1.23 %

Today

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	89
Price	6544.50

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	100
Price	6583

Quantity	100
Price	6588

Holding Details

Latest Corporate Events

Bonus

1 : 1

23-Sep-15

Book Closure

20-Aug-21

22-Aug-21

Dividend

1500 %

25-Jul-25

Company News

26-05-2025

Divi's Laboratories inks ...

26-05-2025

Divi's Laboratories zooms...

24-05-2025

Divi's Laboratories info...

17-05-2025

Divis Laboratories board ...

16-05-2025

Divis Laboratories inform...

30-04-2025

Divi's Laboratories infor...

21-04-2025

Divi's Laboratories inks ...

Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.